Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Raleigh, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIODELIVERY SCIENCES INTERNATIONAL INC has filed 1,391 SEC EDGAR filings since 18 Jan 2000

SEC filing history

Showing 826-850 of 920 matching filings.

Per page
25
Current page
34
3

FORM 3

Filing date
27 Oct 2011
Reporting date
19 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

FORM 8-K

Filing date
25 Oct 2011
Reporting date
21 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

FORM 8-K

Filing date
30 Sep 2011
Reporting date
28 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

FORM 8-K

Filing date
06 Sep 2011
Reporting date
06 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-176476

FORM S-8

Filing date
24 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

FORM 8-K

Filing date
22 Aug 2011
Reporting date
22 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-31361

CT ORDER filing

Filing date
16 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2011
Reporting date
20 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2011
Reporting date
20 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2011
Reporting date
20 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2011
Reporting date
21 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jul 2011
Reporting date
20 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

FORM 8-K

Filing date
26 Jul 2011
Reporting date
25 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

FORM 8-K

Filing date
25 Jul 2011
Reporting date
21 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-31361

DEFINITIVE ADDITIONAL PROXY MATERIALS

Filing date
29 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-31361

DEFINITIVE PROXY MATERIALS

Filing date
13 Jun 2011
Reporting date
21 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

8-K filing

Filing date
03 Jun 2011
Reporting date
02 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-31361

PRELIMINARY PROXY STATEMENT

Filing date
01 Jun 2011
Reporting date
21 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-31361

FORM 8-K AMENDMENT

Filing date
17 May 2011
Reporting date
12 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-31361

FORM 10-Q

Filing date
13 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31361

FORM 8-K

Filing date
13 May 2011
Reporting date
12 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B1 File 333-173261

PROSPECTUS

Filing date
14 Apr 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-173261

EFFECT filing

Filing date
13 Apr 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Apr 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .